Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life

Abstract

The survival benefit seen in this trial was entirely consistent with the NSCLC meta-analysis and subsequent similarly designed large trials. The information on quality of life and cost should enable patients and their clinicians to make more informed treatment choices.